RA Capital Management »

Arcus Biosciences Incorporated shares owned by RA Capital Management

Quarter-by-quarter ownership of Arcus Biosciences Incorporated (RCUS) shares owned by RA Capital Management from 13F filings

Historical chart of RA Capital Management investment in Arcus Biosciences Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Arcus Biosciences Incorporated held by RA Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arcus Biosciences Incorporated by RA Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $16M 1.1M 13.60
2025-06-30 $9.3M 1.1M 8.14
2025-03-31 $8.9M 1.1M 7.85

More positions owned by RA Capital Management

Ascendis Pharma A/s - SH (ASND)
Rhythm Pharmaceuticals SH (RYTM)
Vaxcyte SH (PCVX)
Avidity Biosciences SH (RNA)
Cidara Therapeutics SH (CDTX)
Sionna Therapeutics SH (SION)
89bio SH (ETNB)
Newamsterdam Pharma Co Nv SH (NAMS)
Mineralys Therapeutics SH (MLYS)
Janux Therapeutics SH (JANX)
Arcellx SH (ACLX)
Lenz Therapeutics SH (LENZ)
Tyra Biosciences SH (TYRA)
Edgewise Therapeutics SH (EWTX)
Wave Life Sciences SH (WVE)

View all positions for RA Capital Management

Top funds holding Arcus Biosciences Incorporated

Gilead Sciences
BlackRock
Vanguard Group
Point72 Asset Management
Woodline Partners
Suvretta Capital Management
State Street Corporation
Siren
FMR
Balyasny Asset Management
Geode Capital Management
Dimensional Fund Advisors
Morgan Stanley
Barclays
Bnp Paribas Investment Partners

View all funds holding Arcus Biosciences Incorporated